SHL Telemedicine files 6-K on special meeting invite

SHL Telemedicine Ltd. furnished a current report for August 2025 noting that it issued a press release on August 12, 2025.

Accepted by SEC EDGAR 08/12/2025 - 12:21 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

SHL Telemedicine Ltd. furnished a current report for August 2025 noting that it issued a press release on August 12, 2025. The press release, titled “SHL announces invitation to a Special General Meeting,” is attached as Exhibit 99.1 for shareholders and market participants to review.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did SHL Telemedicine Ltd. (SHLT) disclose in this August 2025 6-K?

SHL Telemedicine disclosed that it issued a press release titled “SHL announces invitation to a Special General Meeting.” The company attached the full press release as Exhibit 99.1 so investors can review the details of the announced meeting.

What is the main subject of SHLT’s attached press release in this 6-K?

The attached press release from SHL Telemedicine relates to an invitation to a Special General Meeting. The 6-K simply states the title of the press release and furnishes it as Exhibit 99.1 without summarizing the agenda or proposals.

When did SHL Telemedicine (SHLT) issue the press release about the Special General Meeting?

SHL Telemedicine issued the press release on August 12, 2025. The same date appears on the 6-K report, which notes that the press release, titled “SHL announces invitation to a Special General Meeting,” is provided as Exhibit 99.1 for reference.

Where can investors find details of SHL Telemedicine’s Special General Meeting?

Investors can find details of the Special General Meeting in Exhibit 99.1 to the 6-K. That exhibit is the full press release titled “SHL announces invitation to a Special General Meeting,” which contains the specific information not summarized in the 6-K body.

Who signed SHL Telemedicine Ltd.’s August 2025 6-K filing?

The 6-K was signed on behalf of SHL Telemedicine Ltd. by Lior Haalman. He is identified in the document as the company’s Chief Financial Officer, acting as the duly authorized representative for this submission under the Securities Exchange Act of 1934.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025

Commission File Number: 001-41641

SHL TELEMEDICINE LTD.

(Translation of registrant’s name into English)

 90 Yigal Alon Street

Tel Aviv 67891, Israel

(Address of principal executive offices)

_____________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒           Form 40-F ☐

EXPLANATORY NOTE

On August 12, 2025, SHL Telemedicine Ltd. (the “Company”) issued a press release titled “SHL announces invitation to a Special General Meeting”. A copy of the press release is furnished herewith as Exhibit 99.1.

Exhibit Description

99.1 Press release, dated August 12, 2025, issued by the Company

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	SHL TELEMEDICINE LTD.
	By:	/s/ Lior Haalman
		Lior Haalman
		Chief Financial Officer

August 12, 2025